• Alizé Pharma 3 Aims to Become Leader in Treatment of Rare Endocrine and Metabolic Disease
  • Pregnant Women Should Monitor Serum Calcium Levels, Researchers Say
  • Entera Bio’s Parathyroid Hormone Therapy Shows Potential in Early Phase 2 Results
  • Chronic Hypoparathyroidism Linked to Higher Risk of Serious Illnesses, Study Finds
  • #NORDSummit – Major Issues on Table for Rare Disease Patients in US as Midterm Elections Approach
  • Risk of Complications After Thyroidectomy Not Increased in Older Patients, Study Reports
  • CHOP Physician Wins ASBMR Award for Bone and Mineral Metabolism Research
  • Advocacy Groups, Doctors Question Rising Prices of Rare Disease Treatments
  • Temporary Hypoparathyroidism Common After Surgery in Thyroiditis Patients, Study Finds
  • Injection of Carbon Nanoparticles During Thyroid Cancer Surgery Helps Prevent Hypoparathyroidism
  • #NORDSummit – More Than 700 Expected to Attend Oct. 15-16 Rare Disease Summit in Washington
  • Measures Taken 24 Hours After Thyroidectomy Can Predict Permanent Hypoparathyroidism, Study Finds